Company Filing History:
Years Active: 2017-2018
Title: Innovations of Yun-Fei Ko in Biotechnology
Introduction
Yun-Fei Ko is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of methods to treat metabolic disorders. With a total of 9 patents to his name, his work focuses on innovative solutions for health-related issues.
Latest Patents
Among his latest patents, one describes a method to reduce blood aspartate transaminase levels, liver weight, hepatic lipid accumulation, and hepatocyte hypertrophy by administering a probiotic bacterium to subjects showing signs of fatty liver disease. This probiotic bacterium can therefore be used to treat fatty liver disease. Another notable patent provides a method to reduce insulin resistance and improve glucose tolerance through the administration of the same probiotic bacterium. This invention can be utilized to treat insulin resistance, metabolic syndrome, and type 2 diabetes.
Career Highlights
Yun-Fei Ko is associated with Chang Gung Biotechnology Corporation, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on public health and the treatment of chronic diseases.
Collaborations
Some of his notable coworkers include Jan Martel and Tsung-Ru Wu, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Yun-Fei Ko's innovative work in biotechnology showcases his commitment to improving health outcomes through scientific advancements. His patents reflect a dedication to addressing critical health issues, making him a valuable contributor to the field.